- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06919276
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025 (EPIC/ADVANCE)
Longitudinal Patterns of Non-Combustible Tobacco Product Use in Adolescents (EPIC) / Assessing Development Patterns of Vaping, Alcohol, Nicotine, and Cannabis Use and Emotional Well-being (ADVANCE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90032
- University of Southern California
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be enrolled in a partnering high school.
Exclusion Criteria:
- Participants who cannot independently understand study consent and the study surveys are ineligible.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mint - Labeling Condition 1
Participants will view an image of a mint-colored and flavored vape with label condition 1.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 2
Participants will view an image of a mint-colored and flavored vape with label condition 2.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 3
Participants will view an image of a mint-colored and flavored vape with label condition 3.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 4
Participants will view an image of a mint-colored and flavored vape with label condition 4.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 5
Participants will view an image of a mint-colored and flavored vape with label condition 5.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 6
Participants will view an image of a mint-colored and flavored vape with label condition 6.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Mint - Labeling Condition 7
Participants will view an image of a mint-colored and flavored vape with label condition 7.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 1
Participants will view an image of a white colored and original vape with label condition 1.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 2
Participants will view an image of a white colored and original vape with label condition 2.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 3
Participants will view an image of a white colored and original vape with label condition 3.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 4
Participants will view an image of a white colored and original vape with label condition 4.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 5
Participants will view an image of a white colored and original vape with label condition 5.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 6
Participants will view an image of a white colored and original vape with label condition 6.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Original - Labeling Condition 7
Participants will view an image of a white colored and original vape with label condition 7.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 1
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 1.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 2
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 2.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 3
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 3.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 4
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 4.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 5
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 5.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 6
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 6.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
|
Experimental: Blueberry - Labeling Condition 7
Participants will view an image of a blue-colored and blueberry flavored vape with label condition 1.
|
Participants will view one vape image (experimental stimulus) and are randomized to a label presented and the color/flavor of the vaping device presented. The label conditions are:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use Intention Susceptibility
Time Frame: 5 minutes
|
This 3-item self-report measure assesses participant interest in trying the vaping device in the future.
A 4-level Likert scale is used: definitely not, probably not, probably yes, definitely yes.
|
5 minutes
|
|
Perceived Health Harms
Time Frame: 5 minutes
|
This 2-item self-report measure assesses participant perception of health harms and risks associated with using the vaping product.
A 4-level Likert scale is used: definitely not, probably not, probably yes, definitely yes.
|
5 minutes
|
|
Anticipated Subjective Effects
Time Frame: 5 minutes
|
This 9-item self-report measure assesses anticipated subjective effects from using the vaping device.
Participants will select all that apply.
|
5 minutes
|
|
Anticipated Impairment/Enhancement
Time Frame: 5 minutes
|
This 4-item self-report measure assesses participant anticipated enhancement or impairment effects on completing different activities due to using the vaping product.
A 5-level Likert scale is used: definitely make it harder, probably make it harder, no effect, probably make it easier, definitely make it easier.
|
5 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UP-23-00483/HS-19-00682
- 5K24DA048160 (U.S. NIH Grant/Contract)
- 5U54CA180905-12 (U.S. NIH Grant/Contract)
- 5R01CA229617-06 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent
-
University of CoimbraRecruitingAdolescent Behavior | Adolescent - Emotional ProblemPortugal
-
National Institute of Environmental Health Sciences...RecruitingAdolescent Health | Pediatrics | Adolescent Development | Reproductive Physiological ProcessesUnited States
-
World Health OrganizationLondon School of Hygiene and Tropical Medicine; University of Ghana; Biomedical... and other collaboratorsRecruitingHealth-Related Behavior | Adolescent Behavior | Adolescent Development | Health Care Seeking BehaviorGhana, Tanzania, Zimbabwe
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD); SoLaHmoCompletedAdolescent Health | Adolescent School Connectedness | Community Based Participatory Research MethodsUnited States
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Aksaray UniversityEskisehir Osmangazi UniversityRecruiting
-
Eastern Mediterranean UniversityRecruiting
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Friends Research Institute, Inc.Conrad N. Hilton FoundationCompletedAdolescent Behavior | Adolescent Health ServicesUnited States
Clinical Trials on Vaping Device Labeling
-
Ohio State University Comprehensive Cancer CenterCompletedNicotine | Nicotine Vaping | E-cigarette UseUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA)Completed
-
Dartmouth-Hitchcock Medical CenterWithdrawnEvaluate the Association of Vaping With SeizuresUnited States
-
Insel Gruppe AG, University Hospital BernSwiss Tobacco Prevention FundsNot yet recruitingNicotine | Vaping | Synthetic Nicotine | Nicotine AnaloguesSwitzerland
-
Hôpital Européen MarseillePeters surgicalCompleted
-
Laval UniversityMinistere de la Sante et des Services SociauxRecruiting
-
University of Ontario Institute of TechnologyThe University of Texas Health Science Center, Houston; University of Waterloo and other collaboratorsActive, not recruiting
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingNicotine Labeling for E-cigarettesUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Food and...Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Institute on Drug Abuse (NIDA); Food and Drug Administration (FDA)RecruitingVapingUnited States